0
0
Loading version...
🔄 Update App
🔍 Check for Updates
Test Notification
🔔 Enable Notifications
📰 Fetch NHK News
🚀 Fetch TechCrunch News
🧪 Experiment
📰 Article Management
📚 Reading List
🎤 Speaking List
📊 Statistics
💻 Software Statistics
Push Admin
Edit Reading
Back to List
Basic Information
Title
Please enter a title.
URL
Please enter a valid URL.
Date
カテゴリID
画像ファイル名
統計情報
単語数:
166語
読了回数:
0回
作成日:
2023/04/08 14:43
更新日:
2025/12/09 05:14
本文
本文
Researchers in Japan say they have transplanted eye cells derived from induced pluripotent stem cells. They say it is the world's first surgery of its kind. The group is led by Fujita Health University Professor Shimmura Shigeto and includes researchers from Keio University. In October, they injected a solution containing about 800,000 iPS-derived cells into the cornea of a patient in his 70s. They performed the transplant at Keio University Hospital in Tokyo. The man had a serious eye disease in which the cornea becomes clouded and the vision reduces. The group says there have been no complications so far, and the man's eyesight shows signs of improvement. Currently, transplantation of the cornea is the only basic remedy for the disease. The group says about 10,000 patients are waiting for a transplant, but only 2,000 procedures are performed each year. Shimmura says the group finally carried out their work after 10 years of research. Induced pluripotent stem cells can develop into various kinds of body tissue.
本文を入力してください。
メモ
メモ・感想
キャンセル
更新
Debug Info:
Saved State:
-
Redirected Flag:
-
Current URL:
-
Refresh
Close
Debug
Send Report
Send Report
Draw Arrow
Clear
Message:
Cancel
Send